$PET
Wag! Group Co.

2023 Q4 Form 10-Q Financial Statement

#000184235623000045 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $21.67M $21.80M
YoY Change 27.22% 41.75%
Cost Of Revenue $1.767M $1.440M
YoY Change 58.62% -62.86%
Gross Profit $19.91M $20.36M
YoY Change 25.02% 77.01%
Gross Profit Margin 91.85% 93.39%
Selling, General & Admin $21.32M $17.44M
YoY Change 25.08% -50.28%
% of Gross Profit 107.08% 85.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $503.0K $414.0K
YoY Change 259.29% 208.96%
% of Gross Profit 2.53% 2.03%
Operating Expenses $21.82M $17.44M
YoY Change 26.99% -50.28%
Operating Profit -$1.913M $2.923M
YoY Change 51.83% -112.4%
Interest Expense -$1.538M $1.683M
YoY Change -8.78% -328.98%
% of Operating Profit 57.58%
Other Income/Expense, Net $0.00 -$10.00K
YoY Change -100.0% -99.93%
Pretax Income -$3.451M -$2.155M
YoY Change -159.46% -94.74%
Income Tax $14.00K $41.00K
% Of Pretax Income
Net Earnings -$3.465M -$2.196M
YoY Change -159.7% -94.63%
Net Earnings / Revenue -15.99% -10.07%
Basic Earnings Per Share -$0.06
Diluted Earnings Per Share -$0.09 -$0.06
COMMON SHARES
Basic Shares Outstanding 39.25M shares 38.78M shares
Diluted Shares Outstanding 38.99M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.32M $22.30M
YoY Change -52.98% -20.43%
Cash & Equivalents $18.32M $22.30M
Short-Term Investments
Other Short-Term Assets $3.428M $3.500M
YoY Change 32.61% -87.62%
Inventory
Prepaid Expenses
Receivables $10.02M $8.485M
Other Receivables $0.00 $0.00
Total Short-Term Assets $31.77M $34.29M
YoY Change -33.0% -45.26%
LONG-TERM ASSETS
Property, Plant & Equipment $1.392M $71.00K
YoY Change 1481.82% 5.97%
Goodwill $4.600M $4.600M
YoY Change 217.02% 222.35%
Intangibles $8.828M $8.036M
YoY Change 247.42% 219.27%
Long-Term Investments
YoY Change
Other Assets $57.00K $63.00K
YoY Change -10.94% -19.23%
Total Long-Term Assets $14.92M $13.94M
YoY Change 205.3% 220.2%
TOTAL ASSETS
Total Short-Term Assets $31.77M $34.29M
Total Long-Term Assets $14.92M $13.94M
Total Assets $46.70M $48.22M
YoY Change -10.73% -28.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.919M $8.686M
YoY Change 38.26% 75.09%
Accrued Expenses $4.401M $4.404M
YoY Change -7.64% -20.73%
Deferred Revenue $1.781M $1.768M
YoY Change -20.21% -19.12%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.751M $1.589M
YoY Change 38.53% 35.93%
Total Short-Term Liabilities $18.40M $17.47M
YoY Change 11.57% -49.51%
LONG-TERM LIABILITIES
Long-Term Debt $25.66M $25.71M
YoY Change 2.78% 4.96%
Other Long-Term Liabilities $988.0K $218.0K
YoY Change 6.47% -66.51%
Total Long-Term Liabilities $26.65M $25.93M
YoY Change 6.74% 5.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.40M $17.47M
Total Long-Term Liabilities $26.65M $25.93M
Total Liabilities $45.05M $44.30M
YoY Change 6.28% -25.86%
SHAREHOLDERS EQUITY
Retained Earnings -$161.7M -$158.3M
YoY Change 8.99% 2.64%
Common Stock $4.000K $4.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.646M $3.923M
YoY Change
Total Liabilities & Shareholders Equity $46.70M $48.22M
YoY Change -10.73% -28.01%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$3.465M -$2.196M
YoY Change -159.7% -94.63%
Depreciation, Depletion And Amortization $503.0K $414.0K
YoY Change 259.29% 208.96%
Cash From Operating Activities -$1.845M -$2.290M
YoY Change -338.06% -25.13%
INVESTING ACTIVITIES
Capital Expenditures $321.0K $10.00K
YoY Change 2040.0% -72.22%
Acquisitions
YoY Change
Other Investing Activities -$1.280M $740.0K
YoY Change 1154.9% -62.78%
Cash From Investing Activities -$1.601M $730.0K
YoY Change 1268.38% -62.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -537.0K -920.0K
YoY Change -96.28% -101.79%
NET CHANGE
Cash From Operating Activities -1.845M -2.290M
Cash From Investing Activities -1.601M 730.0K
Cash From Financing Activities -537.0K -920.0K
Net Change In Cash -3.983M -2.480M
YoY Change -71.09% -104.92%
FREE CASH FLOW
Cash From Operating Activities -$1.845M -$2.290M
Capital Expenditures $321.0K $10.00K
Free Cash Flow -$2.166M -$2.300M
YoY Change -385.0% -25.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 pet Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.97
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
493000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
218000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2023Q3 us-gaap Liabilities
Liabilities
44297000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
42389000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
110000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
110000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36849000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36849000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
4000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
162188000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
158335000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-158269000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-148417000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3923000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
9922000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48220000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52311000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37829000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
3710000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
3027000 usd
pet Platform Operations And Support Expense
PlatformOperationsAndSupportExpense
9630000 usd
pet Platform Operations And Support Expense
PlatformOperationsAndSupportExpense
11035000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
36788000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
24656000 usd
us-gaap Royalty Expense
RoyaltyExpense
1791000 usd
us-gaap Royalty Expense
RoyaltyExpense
0 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14487000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
431000 usd
us-gaap Costs And Expenses
CostsAndExpenses
67576000 usd
us-gaap Costs And Expenses
CostsAndExpenses
67695000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2155000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
553000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2196000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-40931000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9852000 usd
us-gaap Net Income Loss
NetIncomeLoss
-44371000 usd
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38987000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38987000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24534000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24534000 shares
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
9922000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
54000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
225000 usd
CY2023Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
5044000 usd
CY2022Q3 pet Reverse Recapitalization Contingent Consideration Equity Earnout Period
ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriod
P3Y
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39238000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39238000 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
62243000 usd
us-gaap Interest Expense
InterestExpense
4972000 usd
us-gaap Interest Expense
InterestExpense
784000 usd
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-12000 usd
CY2022Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-13708000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-21000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-13708000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-40931000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10326000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-44358000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
79000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.67
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38061000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38061000 shares
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1342000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3787000 usd
CY2023Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2023Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
7531000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
36000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
10000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1065000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2196000 usd
CY2023Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2023Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3923000 usd
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
23859000 shares
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
110265000 usd
CY2022Q1 pet Temporary Equity Stock Issued During Period Shares New Issues
TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
1100000 shares
CY2022Q1 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
10925000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
54000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2350000 usd
CY2022Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
24959000 shares
CY2022Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
121190000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-108409000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1090000 usd
CY2022Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
24959000 shares
CY2022Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
121190000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-109459000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23922000 usd
CY2022Q3 pet Temporary Equity Shares Conversion Of Convertible Securities
TemporaryEquitySharesConversionOfConvertibleSecurities
24959000 shares
CY2022Q3 pet Temporary Equity Value Conversion Of Convertible Securities
TemporaryEquityValueConversionOfConvertibleSecurities
121190000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
121190000 usd
CY2022Q3 pet Stock Issued During Period Value Reverse Recapitalization
StockIssuedDuringPeriodValueReverseRecapitalization
10544000 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1971000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-40931000 usd
CY2022Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7237000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9852000 usd
us-gaap Net Income Loss
NetIncomeLoss
-44371000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3528000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
24016000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
2021000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
224000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1170000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
431000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-13708000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1971000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
553000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-12000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2573000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3698000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
463000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
512000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
48000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
19000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2762000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2662000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-452000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1674000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-491000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
298000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
218000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4624000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3578000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
2550000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
9152000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1470000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
562000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10662000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1952000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
0 usd
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
29445000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
907000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
331000 usd
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
0 usd
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
10925000 usd
pet Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
0 usd
pet Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
11485000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-569000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1376000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
51524000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16662000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
49898000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38966000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2845000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22304000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52743000 usd
us-gaap Interest Paid Net
InterestPaidNet
3724000 usd
us-gaap Interest Paid Net
InterestPaidNet
784000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
23000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
14000 usd
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 usd
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
121188000 usd
pet Non Cash Derivative Instrument Contingent Consideration
NonCashDerivativeInstrumentContingentConsideration
0 usd
pet Non Cash Derivative Instrument Contingent Consideration
NonCashDerivativeInstrumentContingentConsideration
5242000 usd
CY2022 pet Reverse Recapitalization Accrued Transaction Costs
ReverseRecapitalizationAccruedTransactionCosts
9318000 usd
CY2022 pet Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
11726000 usd
CY2022 pet Reverse Recapitalization Reversal Of Additional Paid In Capital Impact Recorded Upon Issuance Of Forward Purchase Agreements
ReverseRecapitalizationReversalOfAdditionalPaidInCapitalImpactRecordedUponIssuanceOfForwardPurchaseAgreements
23203000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:18pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosures as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on various factors, including historical experience, and on various other assumptions that are believed to be reasonable under the circumstances, when these carrying values are not readily available from other sources.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant items subject to estimates and assumptions include, but are not limited to, fair values of financial instruments, assumptions used in the valuation of common and preferred stock, valuation of stock-based compensation and warrants, and the valuation allowance for deferred income taxes. Actual results may differ from these estimates.</span></div>
CY2022Q4 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
1500000 usd
us-gaap Royalty Expense
RoyaltyExpense
1800000 usd
CY2022Q3 pet Proceeds From Redemption Of Common Stock
ProceedsFromRedemptionOfCommonStock
29100000 usd
CY2022Q3 pet Proceeds From Redemption Of Common Stock Classified As Restricted Cash Current
ProceedsFromRedemptionOfCommonStockClassifiedAsRestrictedCashCurrent
23900000 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
5000000 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 pet Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.97
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
91130 shares
CY2022Q3 pet Number Of Lenders
NumberOfLenders
2 lender
CY2022Q3 pet Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.97
CY2022Q3 pet Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.97
CY2022Q3 pet Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.97
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
24700000 usd
CY2022Q3 pet Derivative Instrument Contingent Consideration Liability Shares
DerivativeInstrumentContingentConsiderationLiabilityShares
2393378 shares
CY2022Q3 pet Derivative Instrument Contingent Consideration Liability Price Per Share
DerivativeInstrumentContingentConsiderationLiabilityPricePerShare
10.30
CY2022Q4 pet Derivative Instrument Contingent Consideration Liability Shares
DerivativeInstrumentContingentConsiderationLiabilityShares
1000000 shares
CY2022Q4 pet Derivative Instrument Contingent Consideration Liability Shares Subject To Repurchasing
DerivativeInstrumentContingentConsiderationLiabilitySharesSubjectToRepurchasing
1400000 shares
CY2022Q4 pet Derivative Instrument Contingent Consideration Liability Repurchase Price
DerivativeInstrumentContingentConsiderationLiabilityRepurchasePrice
14800000 usd
CY2022Q4 pet Derivative Instrument Contingent Consideration Liability Shares
DerivativeInstrumentContingentConsiderationLiabilityShares
1000000 shares
CY2022Q4 pet Derivative Instrument Contingent Consideration Liability Proceeds From Release Of Restricted Cash
DerivativeInstrumentContingentConsiderationLiabilityProceedsFromReleaseOfRestrictedCash
9800000 usd
CY2022 pet Cash Acquired Through Reverse Recapitalization
CashAcquiredThroughReverseRecapitalization
28330000 usd
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
5202000 usd
CY2022 pet Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
12488000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9816000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1829000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7987000 usd
CY2022 pet Derivative Instrument Contingent Consideration Liability Proceeds From Release Of Restricted Cash
DerivativeInstrumentContingentConsiderationLiabilityProceedsFromReleaseOfRestrictedCash
9837000 usd
CY2022 pet Reverse Recapitalization Additional Paid In Capital Impact Of Forward Purchase Agreement Net Of Cash Received
ReverseRecapitalizationAdditionalPaidInCapitalImpactOfForwardPurchaseAgreementNetOfCashReceived
4229000 usd
CY2022 pet Reverse Recapitalization Net
ReverseRecapitalizationNet
2589000 usd
CY2022Q3 pet Stock Issued During Period Shares Reverse Recapitalization
StockIssuedDuringPeriodSharesReverseRecapitalization
6524000 shares
CY2022Q3 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
122000 shares
CY2022Q3 pet Stock Issued During Period Shares Reverse Recapitalization And Other
StockIssuedDuringPeriodSharesReverseRecapitalizationAndOther
6646000 shares
CY2022Q3 pet Stock Converted Reverse Recapitalization
StockConvertedReverseRecapitalization
31100000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37746000 shares
CY2022Q3 pet Derivative Instrument Contingent Consideration Liability Shares
DerivativeInstrumentContingentConsiderationLiabilityShares
2393378 shares
CY2022Q3 us-gaap Shares Outstanding
SharesOutstanding
30863283 shares
CY2022Q3 pet Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.97
CY2022Q3 pet Stock Issued During Period Value Reverse Recapitalization Contingent Consideration Equity
StockIssuedDuringPeriodValueReverseRecapitalizationContingentConsiderationEquity
23900000 usd
CY2022Q3 pet Reverse Recapitalization Transaction Costs
ReverseRecapitalizationTransactionCosts
39500000 usd
pet Reverse Recapitalization Transaction Costs
ReverseRecapitalizationTransactionCosts
39500000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
20000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
414000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
424000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
216000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
175000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
163000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1412000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
213000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1199000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.078
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.086
CY2023Q3 us-gaap Goodwill
Goodwill
4600000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
1500000 usd
CY2023Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
49000 usd
CY2023Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
49000 usd
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
9865000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1829000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8036000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3245000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
704000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2541000 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
49000 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
49000 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
3294000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
704000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2590000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1100000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1800000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2200000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
600000 usd
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
300000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1500000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
800000 usd
CY2022Q3 pet Line Of Credit Facility Financial Covenants Minimum Liquidity
LineOfCreditFacilityFinancialCovenantsMinimumLiquidity
5000000 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
357000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1751000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
30227000 usd
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
32335000 usd
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 pet Number Of Lenders
NumberOfLenders
2
CY2021Q3 pet Fair Value Of Warrants Price
FairValueOfWarrantsPrice
1.32
CY2023Q3 pet Class Of Warrant Or Right Redemption Of Warrants Or Rights Reference Price
ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsReferencePrice
16.50
pet Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Trading Days
ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays
20 day
pet Class Of Warrant Or Right Redemption Of Warrants Or Rights Consecutive Trading Days
ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsConsecutiveTradingDays
30 day
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21800000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15379000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
62243000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37829000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3528000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24016000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
44239000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40712000 shares

Files In Submission

Name View Source Status
0001842356-23-000045-index-headers.html Edgar Link pending
0001842356-23-000045-index.html Edgar Link pending
0001842356-23-000045.txt Edgar Link pending
0001842356-23-000045-xbrl.zip Edgar Link pending
exhibit311q32023.htm Edgar Link pending
exhibit312q32023.htm Edgar Link pending
exhibit321q32023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pet-20230930.htm Edgar Link pending
pet-20230930.xsd Edgar Link pending
pet-20230930_g1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pet-20230930_cal.xml Edgar Link unprocessable
pet-20230930_def.xml Edgar Link unprocessable
pet-20230930_lab.xml Edgar Link unprocessable
pet-20230930_pre.xml Edgar Link unprocessable
pet-20230930_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending